Clinical Challenges: Treating Leber Congenital Amaurosis
Ongoing research offers hope for those at risk of vision loss from this severe IRD
Stay updated with breaking news from Eric Pierce. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Ongoing research offers hope for those at risk of vision loss from this severe IRD
RALEIGH - Opus Genetics, launched earlier this year with $19 million in invested capital, has signed an agreement to license its third preclinical program from
Michael Kalberer is just the second person in the world to be part of a groundbreaking medical trial designed to try to restore vision to visually impaired patients.
The unprecedented study involves using the gene-editing technique CRISPR to edit a gene while it's still inside a patient's body. In exclusive interviews, NPR talks with two of the first participants.
Copyright 2021 NPR. To see more, visit https://www.npr.org. A MARTINEZ, HOST: For the first time, doctors are reporting that they have restored vision